摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4,7,7,-三甲基二环[4.1.0]庚烷-3-甲醇 | 73494-49-2

中文名称
4,7,7,-三甲基二环[4.1.0]庚烷-3-甲醇
中文别名
——
英文名称
(2R)-5-Phenyl-2-pentanol
英文别名
(R)-4-phenyl-2-pentanol;(R)-5-phenyl-2-pentanol;(R)-5-phenylpentan-2-ol;5-phenyl-2-pentanol;5-phenyl-2R-pentanol;(R)-alpha-Methylbenzenebutanol;(2R)-5-phenylpentan-2-ol
4,7,7,-三甲基二环[4.1.0]庚烷-3-甲醇化学式
CAS
73494-49-2
化学式
C11H16O
mdl
——
分子量
164.247
InChiKey
ZFVFQRLBTBBQSK-SNVBAGLBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    110 °C(Press: 40 Torr)
  • 密度:
    0.968±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    12
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Biarylcarboxylic Acids and -amides:  Inhibition of Phosphodiesterase Type IV versus [3H]Rolipram Binding Activity and Their Relationship to Emetic Behavior in the Ferret
    摘要:
    In addition to having desirable inhibitory effects on inflammation, anaphylaxis, and smooth muscle contraction, PDE-IV inhibitors also produce undesirable side effects including nausea and vomiting. In general, compounds that inhibit PDE-IV also potently displace [H-3]rolipram from a high-affinity binding site in rat cortex.(1,2) While this binding site has not been identified, it has been proposed to be an allosteric binding site on the PDE-IV enzyme.(3) Preliminary studies have suggested that the emetic potency of PDE-IV inhibitors is correlated with affinity for the brain rolipram binding site rather than potency at inhibiting PDE-IV enzyme activity. Efforts to eliminate the emetic potential of PDE-IV inhibitors were directed toward developing compounds with decreased [H-3]rolipram binding affinity while retaining PDE-IV potency. Thus, a novel series of 4-(3-alkoxy-4-methoxyphenyl)benzoic acids and their corresponding carboxamides were prepared and evaluated for their PDE-IV inhibitory and rolipram binding site properties. Modification of the catechol ether moiety led to phenylbutoxy and phenylpentoxy analogues that provided the desired actitivity profile. Specifically, 4-[3-(5-phenylpentoxy)-4-methoxyphenyl]-2-methylbenzoic acid, 18, was found to exhibit potent PDE-IV inhibitory activity (IC50 0.41 mu M) and possessed 400 times weaker activity than rolipram for the [H-3]rolipram binding site. In vivo, compound 18 was efficacious in the guinea pig aerosolized antigen induced airway obstruction assay (ED(50) 8.8 mg/kg, po) and demonstrated a significant reduction in emetic side effects (ferret, 20% emesis at 30 mg/kg, po).
    DOI:
    10.1021/jm9505066
  • 作为产物:
    描述:
    (2S,3R,E)-5-phenylpent-4-ene-2,3-diol 在 palladium on activated charcoal lithium aluminium tetrahydride 、 氢气Rochelle's salt 作用下, 以 乙醇 为溶剂, 25.0 ℃ 、405.3 kPa 条件下, 反应 4.0h, 生成 4,7,7,-三甲基二环[4.1.0]庚烷-3-甲醇
    参考文献:
    名称:
    Synthesis of the Enantiomeric Forms of 4-Hexanolide (γ-Caprolactone) from the Optically Active 5-Phenyl-4-pentene-2,3-diol Prepared from Cinnamaldehyde and Baker's Yeast
    摘要:
    DOI:
    10.1055/s-1980-28921
  • 作为试剂:
    参考文献:
    名称:
    使用在磷原子上带有伯烷基取代基的反式螯合手性全烷基双膦配体对酮进行不对称氢化硅烷化
    摘要:
    简单酮与二苯基硅烷的不对称氢化硅烷化在 -40 °C 下在铑配合物(0.001-0.01 摩尔量)存在下进行,该配合物与在磷原子上带有线性烷基取代基的反式螯合手性双膦配体(R,R) -(S,S)-Et-、Pr- 或 BuTRAP,得到相应的光学活性 (S)-仲醇,其 ee 高达 97%。使用具有更大 P 取代基的 TRAP 配体的不对称氢化硅烷化导致低得多的对映选择性。EtTRAP-铑催化剂对于具有铑原子配位位点的酮酯的不对称氢化硅烷化也有效(高达 98% ee)。通过使用 2.5 摩尔二苯基硅烷的不对称还原,从相应的二酮中获得了高达 99% ee 的旋光对称二醇。
    DOI:
    10.1246/bcsj.73.485
点击查看最新优质反应信息

文献信息

  • Catalyst-Controlled Diastereoselective Synthesis of Cyclic Amines via C-H Functionalization
    作者:Sailu Munnuri、Adeniyi Michael Adebesin、Mahesh P Paudyal、Muhammed Yousufuddin、Alfonso Dalipe、John R. Falck
    DOI:10.1021/jacs.7b09901
    日期:——
    restrictions, especially in complex molecule synthesis. This report describes a catalyst-controlled regio- and diastereoselective synthesis of N-unprotected pyrrolidines via dirhodium catalyzed intramolecular nitrene insertion into sp3 C-H bonds. The reaction proceeds at rt without external oxidants, nitrene stabilizing groups, or directing functionality. The insights that emerged from the conforma
    由于区分多个相对强的 sp3 CH 键的挑战,这些键的化学行为通常只有细微的差别,因此适用于非活化脂肪族系统的可靠区域和立体化学技术在很大程度上仍然难以捉摸。然而,使用导向基团和/或助剂的方法已经出现,但施加了实际限制,特别是在复杂分子合成中。本报告描述了一种催化剂控制的区域选择性和非对映选择性合成 N-未保护的吡咯烷,通过 dirhodium 催化分子内氮烯插入 sp3 CH 键。反应在室温下进行,无需外部氧化剂、氮烯稳定基团或导向官能团。
  • Substituted dodecahydrotriphenylenes,
    申请人:Pfizer Inc.
    公开号:US04473704A1
    公开(公告)日:1984-09-25
    1,2,3,4,4a,4b,5,6,7,8,8a,12b-Dodecahydro-7-(oxo, hydroxy or amino)-9-hydroxy-11-(alkyl, alkoxy or alkoxyalkyl)triphenylenes, 2,3,3a,3b,4,5,6,7,7a,11b-decahydro-6-(oxo, hydroxy or amino)-8-hydroxy-10-(alkyl, alkoxy or alkoxyalkyl)-1H-cyclopenta[1]phenanthrenes, 2,3,4,4a,4b,5,6,7,8,8a-decahydro-7-(oxo, hydroxy or amino)-9-hydroxy-11-(alkyl, alkoxy, alkoxyalkyl, aralkyl, aralkoxy, aryloxyalkyl or aralkoxyalkyl)-1H-pyrido[1,2-f]phenanthridines, and 1,2,3,3a,3b,4,5,6,7,7a-decahydro-6-(oxo, hydroxy or amino)-8-hydroxy-10-(alkyl, alkoxy or alkoxyalkyl)pyrrolo[1,2-f]phenanthridines and derivatives are valuable as central nervous system active agents or as intermediates to compounds having such activity.
    1,2,3,4,4a,4b,5,6,7,8,8a,12b-十二氢-7-(氧代、羟基或氨基)-9-羟基-11-(烷基、烷氧基或烷氧基烷基)三苯基烯,2,3,3a,3b,4,5,6,7,7a,11b-十氢-6-(氧代、羟基或氨基)-8-羟基-10-(烷基、烷氧基或烷氧基烷基)-1H-环戊[1]菲,2,3,4,4a,4b,5,6,7,8,8a-十氢-7-(氧代、羟基或氨基)-9-羟基-11-(烷基、烷氧基、烷氧基烷基、芳烷基、芳烷氧基、芳氧基烷基或芳烷氧基烷基)-1H-吡啶并[1,2-f]菲啶,以及1,2,3,3a,3b,4,5,6,7,7a-十氢-6-(氧代、羟基或氨基)-8-羟基-10-(烷基、烷氧基或烷氧基烷基)吡咯并[1,2-f]菲啶及其衍生物,作为中枢神经系统活性剂或作为具有此类活性的化合物的中间体具有重要价值。
  • The biogenic amine transporter activity of vinylogous amphetamine analogs
    作者:Ann M. Decker、John S. Partilla、Michael H. Baumann、Richard B. Rothman、Bruce E. Blough
    DOI:10.1039/c6md00245e
    日期:——
    A series of vinylogous amphetamine analogs was synthesized and examined for their activity at biogenic amine transporters and serotonin-2 receptor (5-HT2) subtypes. (1S,3E)-1-Methyl-4-phenyl-but-3-enylamine (S-6) is a potent dual dopamine/serotonin (DA/5-HT) releaser with no activity at 5-HT2 receptors. This unique profile of actions suggests that analog S-6 is a viable lead compound for identifying
    合成了一系列乙烯基苯丙胺类似物,并检查了它们对生物胺转运蛋白和血清素2受体(5-HT 2)亚型的活性。(1 S,3 E)-1-甲基-4-苯基-丁-3-烯胺(S - 6)是一种有效的多巴胺/ 5-羟色胺双重释放剂(DA / 5-HT),对5-HT 2受体没有活性。这种独特的作用表明,类似物S - 6是一种可行的先导化合物,可用于鉴定具有治疗益处和减少滥用风险的DA / 5-HT释放剂的新结构类别。
  • Substituted hexahydropyrrolo[1,2-a]-quinolines, hexahydro-1H-pyrido[1,2-a]-
    申请人:Pfizer Inc.
    公开号:US04476131A1
    公开(公告)日:1984-10-09
    Tricyclic benzo fused compounds of the formula ##STR1## and pharmaceutically acceptable cationic and acid addition salts thereof, wherein n is zero, 1 or 2, and t is 1 or 2; M is CH or N, R.sub.1 is H or certain acyl groups; Q is CO.sub.2 R.sub.4, COR.sub.5, C(OR.sub.7)R.sub.5 R.sub.6, CN, CONR.sub.9 R.sub.10, CH.sub.2 NR.sub.9 R.sub.10, CH.sub.2 NHCOR.sub.11, CH.sub.2 NHSO.sub.2 R.sub.12, 5-tetrazolyl or when n is 1, Q and OR.sub.1 together form a lactone or certain reduced derivatives thereof; and Z is certain alkyl, alkoxy, alkoxyalkyl, aralkyl, aralkoxy, aryloxyalkyl or aralkoxyalkyl groups, are valuable central nervous system active agents, methods for their use, pharmaceutical compositions containing them and certain intermediates therefor.
    三环苯并化合物的结构式为##STR1##及其药学上可接受的阳离子和酸盐,其中n为零、1或2,t为1或2;M为CH或N,R.sub.1为H或特定的酰基;Q为CO.sub.2 R.sub.4、COR.sub.5、C(OR.sub.7)R.sub.5 R.sub.6、CN、CONR.sub.9 R.sub.10、CH.sub.2 NR.sub.9 R.sub.10、CH.sub.2 NHCOR.sub.11、CH.sub.2 NHSO.sub.2 R.sub.12、5-四唑基或当n为1时,Q和OR.sub.1共同形成内酯或其还原衍生物;Z为特定的烷基、烷氧基、烷氧基烷基、芳基烷基、芳基氧基、芳基氧基烷基或芳基烷氧基烷基基团,是有价值的中枢神经系统活性剂,其使用方法、含有它们的药物组合物以及某些中间体。
  • Highly enantioselective hydrosilylation of simple ketones catalyzed by rhodium complexes of P-chiral diphosphine ligands bearing tert-butylmethylphosphino groups
    作者:Tsuneo Imamoto、Takuma Itoh、Yoshinori Yamanoi、Rintaro Narui、Kazuhiro Yoshida
    DOI:10.1016/j.tetasy.2006.02.008
    日期:2006.2
    P-Chiral diphosphine ligands, (S,S)-1,2-bis(tert-butylmethylphosphino)ethane [(S,S)-t-Bu-BisP∗], (R,R)-bis(tert-butylmethylphosphino)methane [(R,R)-t-Bu-MiniPHOS], and (R,R)-2,3-bis(tert-butylmethylphosphino)quinoxaline [(R,R)-QuinoxP∗], were applied to the rhodium-catalyzed enantioselective hydrosilylation of simple ketones. The corresponding secondary alcohols were obtained in high yields with good
    P-手性二膦配体,(S,S)-1,2-双(叔丁基甲基膦基)乙烷[(S,S)-t -Bu-BisP ∗ ],(R,R)-双(叔丁基甲基膦基)甲烷[(R,R)-t -Bu-MiniPHOS]和(R,R)-2,3-双(叔丁基甲基膦基)喹喔啉[(R,R)-QuinoxP ∗,被应用于铑催化的简单酮的对映选择性氢化硅烷化。以高收率获得相应的仲醇,其中良好至优异的对映体过量高达99%。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐